Manuka honey in clinical wound care — the strongest applied evidence base, and where food-grade ends and medical-grade begins.
Wound care is the part of the Manuka honey story where the gap between mechanism and clinical evidence is narrowest. It is the application that hospitals, district nurses, and tissue viability specialists actually use, with regulated medical-grade products, established protocols, and a substantial clinical literature behind it. Most of what is true about Manuka honey as a serious therapeutic agent is true here — and that is also why this is the easiest area to mislead people about, by collapsing food-grade and medical-grade into a single category.
This hub collects the editorial frame for the cluster: what is genuinely well-supported, where the line between household first-aid and clinical care belongs, and how the components (compound chemistry, indications, applied research) fit together.
The detailed clinical case lives on the skin and wound care health topic page, which covers mechanisms, the food-grade vs medical-grade distinction, and the practical use envelope. The narrower subset of evidence on antibiotic-resistant infection — and one of the more rigorously studied applied questions — is covered on the MRSA page and in the linked randomised controlled trial summary. The compound chemistry that underlies the antibacterial side of wound care is on the methylglyoxal (MGO) page.
The honest evidence summary across the cluster: medical-grade Manuka honey dressings have a real and unusual evidence base — multiple randomised trials, systematic reviews, and product registrations support their use in chronic venous leg ulcers, biofilm-laden wounds, and antibiotic-resistant infection contexts. Effect sizes are not dramatic, the evidence base is concentrated rather than uniformly large, and the clinical claims are most defensible when narrowly scoped to what was actually studied. The randomised trial summarised on this site reported sustained activity over 14 days against MRSA-colonised chronic venous leg ulcers with no detected resistance-associated mutations on whole-genome sequencing of paired isolates — methodology closer to what an antimicrobial-pharmacology question requires than the in-vitro work that dominates the broader literature.
For minor superficial scrapes in healthy people, ordinary first-aid practice is the standard, and a small amount of food-grade Manuka honey applied to a clean superficial graze is a long-standing tradition with no obvious downside. For anything beyond that — chronic wounds, ulcers, diabetic skin breaks, infected wounds, surgical wounds with delayed healing, deep or penetrating injuries, animal bites, or burns beyond superficial sunburn — the right path is clinical assessment, with regulated medical-grade Manuka honey dressings used where they are clinically indicated. Medical-grade dressings are filtered, sterilised, and produced under medical-device standards; they are not the same product as a retail jar, even a premium UMF-graded one.
If a wound is showing signs of infection — spreading redness, swelling, heat, pus, fever, or red streaking — that is a reason to seek medical care promptly, not to escalate to a higher grade of honey. The skin and wound care page walks through where the line is, and the MRSA page goes deeper into the antibiotic-resistant infection question specifically.